Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-4181116

  • Global ENT Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

  • Publish: July 2016 | Report Code: HME-4181116

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

ENT devices refer to the equipment that are mainly used for therapy, diagnosis and surgery of any disorder related to ear, nose or throat. These devices help in correcting problems related to smelling, hearing, snoring or speaking. A wide range of ENT devices are available in the market including balloon sinus dilation devices, powered surgical instruments, handheld surgical instruments, CO2 lasers, hearing implants, hearing aids, image-guided surgery systems and so on. ENT devices market is estimated to grow at a CAGR of 7% by 2023. High prevalence rate of chronic sinusitis is expected to fuel the market demand for ENT devices. In U.S., approx. 37 million people get affected by sinusitis, amongst which 33 million are chronic sinusitis patients. Adoption of ENT market is driven by the following reasons:

  • Rapidly Growing Geriatric Population
  • High Prevalence Rate of Chronic Sinusitis
  • Rising Adoption of Minimally Invasive ENT Procedures
  • Technological Advancements
  • Favourable Reimbursement Scenario in Developed Nations for ENT Procedures
  • Increasing Prominent Players in The ENT Devices Market
  • Growing Trend for Customized Implants








  The increasing prevalence of sinusitis is anticipated to create significant opportunities for the manufacturers of ENT devices in the coming years. The other factors that are contributing significantly towards the growth of ENT devices market include rapidly growing geriatric population, favourable reimbursement policies in developed nations for ENT procedures and technological advancements. Moreover, high cost of ENT procedures and devices is anticipated to hinder the growth of ENT devices market. The cost of balloon sinus dilation device ranges from $300 to $3000 per balloon and for one cochlear implant the average cost can range from $40,000 to $100,000 depending on the center of surgery and individual need. Such high cost of implants and devices can restraint the demand for ENT devices. Rising demand for cosmetic ENT procedures is estimated to create a significant opportunity for the key players of ENT devices market.

Source: OBRC Analysis

The ENT devices market can be segregated on the basis of product type and end-users. On the basis of product type, the ENT devices market is bifurcated into:

  • Surgical Devices
  • Diagnostic Devices
  • Hearing Implant
  • Image-Guided Surgery Systems
  • Hearing Aids
  • Co2 Lasers







In 2015, hearing aids are anticipated to account for the largest share in the ENT devices market in product type. In 2015, hearing aid’s net sales grew to 3.36 million units in the U.S., a 7.17% increase over 3.13 million units in 2014. Moreover, hearing implants is expected to be the fastest growing segment owing to increasing geriatric population, high prevalence of hearing loss, technological advancements and improved healthcare structure in the developing economies.

Surgical devices are further segregated into:

  • Radiofrequency Handpieces
  • Balloon Sinus Dilation Devices
  • Powered Surgical Instruments
  • Handheld Instruments
  • Ear Tubes
  • Ent Supplies
  • Voice Prosthesis Devices








 Handheld instruments market also possesses rhinology instruments, laryngeal instruments, otology instruments, head and neck surgery instruments and other handheld instruments. 

In addition to it, diagnostic devices are also bifurcated into:

  • Hearing Screening Devices  
  • Endoscopes



ENT devices market can also be segmented on the basis of end-users includes:

  • Hospitals
  • ENT Clinics
  • Home Users
  • Ambulatory Settings





Amongst them, ambulatory settings are anticipated to grow at a highest CAGR during 2016-2022.

The revenue for the above end-user segments are specific to the ENT device market. however, the total revenue of these end user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up product segment.

Geographically, the global ENT market has been segmented on the basis of four major region, which include:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America dominates the ENT devices market owing to favourable government policies, presence of sophisticated healthcare infrastructure and rising awareness level among practitioners and patients.  According to national institute on deafness and other communication disorders, in the United States, about 2 to 3 out of every 1,000 children are born with a detectable level of hearing loss in either one or both ears. Around 15% of American adults aged 18 and over report some or the other problem in hearing.  According to NIDCD (National Institute on Deafness and Other Communication Disorders), approx. 26 million between the age of 20-69 have high frequency hearing loss owing to noise at work or during leisure activities. Asia Pacific is estimated to be the fastest growing region due to rise in disposable income in developing countries, increasing demand for minimally invasive ENT surgeries, growing geriatric population and less stringent regulatory guidelines. Growing concern among people for ear, nose and throat disorders is also anticipated to influence the demand for EHR devices in Asia Pacific.

The major market players of the global ENT market are:

  • Medtronic PLC
  • Karl STORZ GmbH & Co.
  • Olympus Corporation
  • Stryker Corporation
  • Acclarent Inc.
  • Sonova Holdings AG
  • Hoya Corporation
  • William Demant Holdings A/S
  • Cochlear Limited.










Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.

In March 2015, Medtronic PLC acquired Sophono Inc., a privately held manufacturer and developer of innovative magnetic hearing implants in Boulder, Colorado. This acquisition enabled Medtronic’s ENT division to continue its focus on novel therapies and innovative technology solutions. Sophono’s magnetic bone conduction hearing implants have made its presence felt in 42 countries and have been implanted in 4,000 patients.

Why to buy the report:

This report will provide you:

  • Provide you the business strategies adopted by market player such as In March 2015, Medtronic PLC acquired Sophono Inc., a privately held manufacturer and developer of innovative magnetic hearing implants.  
  • Provide in detail the different segments such as by products and end-users which are affecting the global ENT market.
  • Provide you the patent analysis of the ENT market.
  • Identify, understand, and the strength, opportunities, challenges and threat of the ENT market.
  • Provide revenues of major players of the market such as Medtronic PLC, stryker corporation.
  • Provide you various the regulatory policies which are affecting the global ENT market.







How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global ENT market offers the longest chain of market segmentation covering major market segmentation based on products and end users. Report tracks the major market trends in the global ENT market such as increasing prevalence of ear, nose, and throat related traumas & infections and so on.   For each market segments covered in global ENT market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the ENT industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, See Saw analysis, and Porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key Findings of the global ENT market:

  • Increasing prevalence of ear, nose, and throat related traumas and infections, the high prevalence of chronic sinusitis and growing trend for customized implants are fuelling growth in the global ENT device market.
  • North America is anticipated to account the largest revenue share in 2016.
  • Hearing aids are anticipated to account for the largest share in the ENT devices market in product type.
  • Increasing government support
  • Ambulatory setting is the major segment of end-user.
  • Acquisition is the key strategy adopted by the various market players of global ENT device market.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL ENT DEVICE MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360 DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. PATENT ANALYSIS
2.6.6. PRICING ANALYSIS
2.6.7. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. RAPIDLY GROWING GERIATRIC POPULATION
3.1.2. HIGH PREVALENCE RATE OF CHRONIC SINUSITIS
3.1.3. RISING ADOPTION OF MINIMALLY INVASIVE ENT PROCEDURES
3.1.4. TECHNOLOGICAL ADVANCEMENTS
3.1.5. FAVORABLE REIMBURSEMENT SCENARIO IN DEVELOPED NATIONS FOR ENT PROCEDURES
3.1.6. INCREASING PROMINENT PLAYERS IN THE ENT DEVICES MARKET
3.1.7. GROWING TREND FOR CUSTOMIZED IMPLANTS
3.2. MARKET RESTRAINTS
3.2.1. HHIGH COST OF ENT DEVICES AND PROCEDURES
3.2.2. LACK OF REIMBURSEMENT FOR HEARING AIDS
3.2.3. PRESENCE OF SOCIAL STIGMAS
3.2.4. CHANGES IN REIMBURSEMENT POLICY FOR TRACHEOESOPHAGEAL VOICE PROSTHESIS DEVICES (TEP) IN THE U.S
3.3. MARKET OPPORTUNITIES
3.3.1. DEMAND FROM EMERGING ECONOMIES
3.3.2. COSMETIC ENT PROCEDURES ARE HIGHLY DEMANDED
3.4.  MARKET CHALLENGES 
3.4.1. LACK OF SKILLED OTOLARYNGOLOGISTS
3.4.2. PRESENCE OF SMALL PLAYERS
 
4. MARKET SEGMENTATION 
4.1. GLOBAL ENT DEVICE MARKET BY PRODUCT 
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL  SURGICAL DEVICES MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL  DIAGNOSTIC DEVICES MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL  HEARING IMPLANTS MARKET 
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.1.5.4. GLOBAL  IMAGE-GUIDED SURGERY SYSTEMS MARKET 
4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.4.4. KEY CONCLUSIONS
4.1.5.5. GLOBAL  HEARING AIDS  MARKET 
4.1.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.5.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.5.4. KEY CONCLUSIONS
4.1.5.6. GLOBAL  CO2 LASERS MARKET 
4.1.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.6.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.6.4. KEY CONCLUSIONS
4.2. GLOBAL ENT DEVICE MARKET BY END-USER  
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL  HOSPITALS  MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. KEY PLAYERS & KEY PRODUCTS 
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL  ENT CLINICS MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. KEY PLAYERS & KEY PRODUCTS 
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL  HOME USERS MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. KEY PLAYERS & KEY PRODUCTS 
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. GLOBAL   AMBULATORY SETTINGS MARKET
4.2.5.4.1. APPLICATION
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4. KEY PLAYERS & KEY PRODUCTS 
4.2.5.4.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGER & ACQUISITION
5.1.2. LIST OF JOINT VENTURE
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL ENT DEVICE MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. RUSSIA
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ATOS MEDICAL AB.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2.  KARL STORZGMBH& CO. KG
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS 
7.2.5. STRATEGIC ANALYSIS
7.3. STRYKER CORPORATION
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. OLYMPUS CORPORATION
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. COCHLEAR LIMITED
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS 
7.5.5. STRATEGIC ANALYSIS
7.6. SONOVA HOLDING AG
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.6.5. STRATEGIC ANALYSIS
7.7. MEDTRONIC PLC
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS 
7.7.5. STRATEGIC ANALYSIS
7.8. SMITH & NEPHEW PLC
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.8.5. STRATEGIC ANALYSIS
7.9. ACCLARENT, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.9.5. STRATEGIC ANALYSIS
7.10. HOYA CORPORATION
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. WILLIAM DEMANT HOLDING A/S
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. WIDEX A/S
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. SIEMENS HEALTHCARE
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. STARKEY LABORATORIES INC..
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. RION CO., LTD.
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL ENT DEVICE MARKET BY PRODUCT 2014-2023 ($ MILLION)
2. GLOBAL SURGICAL DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL DIAGNOSTIC DEVICE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL HEARING IMPLANTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBALIMAGE-GUIDED SURGERY SYSTEMS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
6. GLOBAL   HEARING AIDS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL CO2 LASERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL ENT DEVICE MARKET BY END-USER 2014-2023 ($ MILLION)
9. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL   ENT CLINICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL HOME USERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL AMBULATORY SETTINGS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. NORTH AMERICA ENT DEVICE MARKET 2014-2023 ($ MILLION)
14. EUROPE ENT DEVICE MARKET 2014-2023 ($ MILLION)
15. ASIA PACIFIC ENT DEVICE MARKET 2014-2023 ($ MILLION)
16. REST OF THE WORLD ENT DEVICE MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL SURGICAL DEVICES MARKET 2014-2023 ($ MILLION)
2. GLOBAL DIAGNOSTIC DEVICE MARKET 2014-2023 ($ MILLION)
3. GLOBAL HEARING IMPLANTS MARKET 2014-2023 ($ MILLION)
4. GLOBAL IMAGE-GUIDED SURGERY SYSTEMS MARKET 2014-2023 ($ MILLION)
5. GLOBAL   HEARING AIDS MARKET 2014-2023 ($ MILLION)
6. GLOBAL CO2 LASERS MARKET 2014-2023 ($ MILLION)
7. GLOBAL HOSPITALS MARKET 2014-2023 ($ MILLION)
8. GLOBAL   ENT CLINICS MARKET 2014-2023 ($ MILLION)
9. GLOBAL HOME USERS MARKET 2014-2023 ($ MILLION)
10. GLOBAL AMBULATORY SETTINGS MARKET 2014-2023 ($ MILLION)
11. UNITED STATES (U.S.) ENT DEVICE MARKET 2014-2023 ($ MILLION)
12. CANADA ENT DEVICE MARKET 2014-2023 ($ MILLION)
13. UNITED KINGDOM (UK) ENT DEVICE MARKET 2014-2023 ($ MILLION)
14. FRANCE ENT DEVICE MARKET 2014-2023 ($ MILLION)
15. GERMANY ENT DEVICE MARKET 2014-2023 ($ MILLION)
16. RUSSIA ENT DEVICE MARKET 2014-2023 ($ MILLION)
17. ROE ENT DEVICE MARKET 2014-2023 ($ MILLION)
18. INDIA ENT DEVICE MARKET 2014-2023 ($ MILLION)
19. CHINA ENT DEVICE MARKET 2014-2023 ($ MILLION)
20. JAPAN ENT DEVICE MARKET 2014-2023 ($ MILLION)
21. AUSTRALIA ENT DEVICE MARKET 2014-2023 ($ MILLION)
22. ROAPAC ENT DEVICE MARKET 2014-2023 ($ MILLION)
23. LATIN AMERICA ENT DEVICE MARKET 2014-2023 ($ MILLION)
24. MENA ENT DEVICE MARKET 2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion